WuXi Biologics is trading 4.33% lower at HK$47.26 in the supplied price context for October 22, 2026, with no clear company-specific reason identified. - The latest identified company news was a sustainability award announced October 21, not an evident negative catalyst. - Provided major-index moves were flat, offering no clear explanation for the decline. - No reliable same-day volume figure or direct cause was identified.